None of the 29 investors followed here reported a position in PRCT in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a PRCT trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 1, 2026 | Mack MichaelDirector | Stock Award(Grant) at price 0.00 per share. | 7.7K | — |
| Sep 8, 2026 | Nouri AlalehOfficer | Sale at price 20.95 per share. | 297 | $6.22K |
| Sep 8, 2026 | Waters KevinChief Financial Officer | Sale at price 20.95 per share. | 373 | $7.82K |
| Sep 8, 2026 | Templin Barry LChief Technology Officer | Sale at price 20.95 per share. | 373 | $7.82K |
| Aug 12, 2026 | Nouri AlalehOfficer | Stock Award(Grant) at price 0.00 per share. | 23K | — |
| Aug 12, 2026 | Waters KevinChief Financial Officer | Stock Award(Grant) at price 0.00 per share. | 29.5K | — |
| Aug 12, 2026 | Templin Barry LChief Technology Officer | Stock Award(Grant) at price 0.00 per share. | 26.2K | — |
| Aug 12, 2026 | Sharma PoojaOfficer | Stock Award(Grant) at price 0.00 per share. | 23.6K | — |
| Aug 6, 2026 | Wood Larry LChief Executive Officer | Purchase at price 20.85 per share. | 23.9K | $498.31K |
| Jun 8, 2026 | Prescott Thomas MDirector | Stock Award(Grant) at price 0.00 per share. | 3.3K | — |
| Jun 8, 2026 | Moll Frederic HDirector | Stock Award(Grant) at price 0.00 per share. | 3.3K | — |
| Jun 8, 2026 | Harris Taylor CDirector | Stock Award(Grant) at price 0.00 per share. | 3.3K | — |
| Jun 8, 2026 | Little Elisabeth SandovalDirector | Stock Award(Grant) at price 0.00 per share. | 3.3K | — |
| Jun 8, 2026 | Garrett MaryDirector | Stock Award(Grant) at price 0.00 per share. | 3.3K | — |
| Jun 8, 2026 | Puckett DanielDirector | Stock Award(Grant) at price 0.00 per share. | 3.3K | — |
| Jun 8, 2026 | Dodrill Amy M.Director | Stock Award(Grant) at price 0.00 per share. | 3.3K | — |
| Jun 8, 2026 | Desai Antal RohitDirector | Stock Award(Grant) at price 0.00 per share. | 3.3K | — |
| Jun 7, 2026 | Nouri AlalehOfficer | Sale at price 28.48 per share. | 285 | $8.12K |
| Jun 7, 2026 | Waters KevinChief Financial Officer | Sale at price 28.48 per share. | 357 | $10.17K |
| Jun 7, 2026 | Templin Barry LChief Technology Officer | Sale at price 28.48 per share. | 358 | $10.20K |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -7.9 | -21.7 | 10.2 | -3.9 | 9.5 | -14.2 | -17.5 | 13.9 | -14.1 | 7.4 | −37.8% | ||
| 2025 | -10.0 | -11.3 | -9.4 | -7.3 | 7.4 | -0.7 | -15.8 | -17.2 | -11.2 | -4.7 | -6.9 | -0.7 | −60.9% |
| 2024 | 10.5 | 4.4 | 2.2 | 7.2 | 25.3 | -8.0 | 3.7 | 24.8 | 1.4 | 12.3 | 6.2 | -15.8 | +92.1% |
| 2023 | -6.4 | -3.7 | -24.2 | 7.0 | 10.1 | 5.7 | -2.6 | -1.0 | -3.8 | -18.3 | 38.4 | 13.1 | +0.9% |
| 2022 | -25.9 | 34.7 | 40.1 | 1.6 | 10.0 | -16.4 | 17.2 | 5.7 | 2.4 | 9.6 | -5.6 | -3.2 | +66.1% |
| 2021 | 12.0 | -23.6 | -23.4 | −34.4% |
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
Buy / hold / sell counts